These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26470498)

  • 1. The Corporate Practice of Medicine: An Old Conflict Continues in New Forms.
    Johnson S
    Md Med; 2015; 16(2):15-7. PubMed ID: 26470498
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding corporate responsibility: culture and complicity.
    Degeling C; Townley C; Rogers W
    Am J Bioeth; 2011 Sep; 11(9):18-20. PubMed ID: 21877967
    [No Abstract]   [Full Text] [Related]  

  • 3. Foxes guarding the henhouse: systemic responsibility for corporate harms.
    Hall A
    Am J Bioeth; 2011 Sep; 11(9):10-1. PubMed ID: 21877963
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenging the idea of corporate responsibility: physician's obligation to disclose information.
    Chiapperino L; Oishi JO
    Am J Bioeth; 2011 Sep; 11(9):20-1. PubMed ID: 21877968
    [No Abstract]   [Full Text] [Related]  

  • 5. Corporate moral culpability in health care: when the implications don't fit the crime.
    Harter TD
    Am J Bioeth; 2011 Sep; 11(9):12-3. PubMed ID: 21877964
    [No Abstract]   [Full Text] [Related]  

  • 6. Blind spots.
    Trachtman H
    Am J Bioeth; 2011 Sep; 11(9):16-8. PubMed ID: 21877966
    [No Abstract]   [Full Text] [Related]  

  • 7. Does fortune foul fidelity?
    Spillman MA; Sade R
    Am J Bioeth; 2011 Sep; 11(9):14-5. PubMed ID: 21877965
    [No Abstract]   [Full Text] [Related]  

  • 8. Impairing loyalty: corporate responsibility for clinical misadventure.
    Kipnis K
    Am J Bioeth; 2011 Sep; 11(9):3-9. PubMed ID: 21877962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: Lack of scientific influences on epidemiology.
    Phillips CV
    Int J Epidemiol; 2008 Feb; 37(1):59-64; discussion 65-8. PubMed ID: 18245053
    [No Abstract]   [Full Text] [Related]  

  • 10. The Change in and Corporatization of Medicine.
    Ransom G
    Md Med; 2015; 16(2):7. PubMed ID: 26470494
    [No Abstract]   [Full Text] [Related]  

  • 11. The conflict and paradox of medical practice and corporate medicine.
    Kahn L
    Circulation; 1986 Oct; 74(4):659-63. PubMed ID: 3757180
    [No Abstract]   [Full Text] [Related]  

  • 12. Corporate influences on epidemiology.
    Pearce N
    Int J Epidemiol; 2008 Feb; 37(1):46-53. PubMed ID: 18245050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The corporate practice of medicine doctrine revisited.
    Chenen AR
    Med Staff Couns; 1991; 5(1):61-2. PubMed ID: 10111823
    [No Abstract]   [Full Text] [Related]  

  • 14. Seeking expert advice. Organizations see no conflict of interest as IT veterans join firms' boards.
    Conn J
    Mod Healthc; 2012 May; 42(20):18. PubMed ID: 22666966
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 16. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 17. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Coli R
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117081
    [No Abstract]   [Full Text] [Related]  

  • 18. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Adler AC
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117082
    [No Abstract]   [Full Text] [Related]  

  • 19. Elsevier should divest itself of either its medical publishing or pharmaceutical services division.
    Jureidini J; Clothier R
    Lancet; 2009 Aug; 374(9687):375. PubMed ID: 19647600
    [No Abstract]   [Full Text] [Related]  

  • 20. Elsevier should divest itself of either its medical publishing or pharmaceutical services division.
    Reller T
    Lancet; 2009 Aug; 374(9687):375-6. PubMed ID: 19647599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.